Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › onchocerciasis

Onchocerciasis

Part of Filariasis

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for onchocerciasis

3 trials tracked for onchocerciasis: 1 in phase 3 or 4.

3Trials tracked
1Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 1 Phase 2 1 Phase 1 1
  1. Phase 3 Safety of a Single Dose of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant Albendazole Completed
  2. Phase 2 Safety and Efficacy of IDA for Onchocerciasis Completed
  3. Phase 1 A Pharmacokinetic and Safety Study of Moxidectin to Identify an Optimal Dose for Treatment of Children 4 to 11 Years Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Review of ivermectin MDA for onchocerciasis and hookworm co-infections in endemic regions
Neurology Sys. Review
Review of ivermectin MDA for onchocerciasis and hookworm co-infections in endemic regions Ivermectin helps clear hookworm even when people also carry river blindness
This narrative review synthesizes evidence on preventative chemotherapy and Mass Drug Administration with ivermectin for onchocerciasis and …
A review shows ivermectin treatment improves outcomes for people infected with both river blindness and hookworm, though more data on immune…
Frontiers May 16, 2026
Systematic scoping review shows declining filarial infection prevalence in Latin America from 1946 to 2025
Dermatology Cohort
Systematic scoping review shows declining filarial infection prevalence in Latin America from 1946 to 2025 Filaria Rates Drop After Mass Drug Campaigns
This systematic scoping review synthesizes data on lymphatic filariasis, onchocerciasis, and mansonellosis across Latin America from 1946 to…
Infection rates for disfiguring parasitic diseases have dropped sharply in parts of Latin America after years of mass drug campaigns, but on…
Frontiers Apr 25, 2026